PPARG and metabolic syndrome: Peroxisome proliferator-activated receptor gamma (PPARγ) is a primary transcriptional factor that regulates adipogenesis and also operates as a known therapeutic target for type 2 diabetes mellitus and dyslipidemia to increase the lipid storage capacity of WAT [6].